RE: This is going on the NHS...1 Apr 2026 09:22
Slacker - maybe you can apply yourself to the task here - it is actually straight forward and makes perfect mathematical sense - well it does to me anyway.
If you were to use the formuli : C= F ( OVER ) N = V
Where:
• F = fixed annual lab + regulatory + bioinformatics overhead
• N = number of tests per year
• V = variable cost per test (qPCR reagents, consumables, labour)
Then:
• is probably £8–£20 at scale
• is likely £3–6m based on OBD’s operating losses and lab footprint
• So at 100k tests/year:
PLEASE ENTER YOUR ANSWER HERE - £ ??? THIS IS YOUR OPORTUNITY TO FILL IN THE CALCULATION - CAN YOU DO IT SLACKER :)
If OBD ever hits high‑volume adoption (e.g., PSE entering mainstream screening), the gross margin could become extremely high, because qPCR‑based diagnostics can be priced at £200–£500 while costing <£30 to run.
OSD - Sheltering from the Greek biblical rain - but utilising his maths well I think :)